Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter Study

European Association for the Study of the Liver, 2018, EASL clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 69, 182, 10.1016/j.jhep.2018.03.019 European Association for the Study of the Liver, 2012, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 56, 908, 10.1016/j.jhep.2011.12.001 Llovet, 2008, Design and endpoints of clinical trials in hepatocellular carcinoma, J Natl Cancer Inst, 100, 698, 10.1093/jnci/djn134 Mazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, New Engl J Med, 334, 693, 10.1056/NEJM199603143341104 Clavien, 2012, Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report, Lancet Oncol, 13, e11, 10.1016/S1470-2045(11)70175-9 Yao, 2008, Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis, Hepatology, 48, 819, 10.1002/hep.22412 Barakat, 2010, Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis, Liver Transplant, 16, 289, 10.1002/lt.21994 Chapman, 2008, Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation, Ann Surg, 248, 617, 10.1097/SLA.0b013e31818a07d4 De Luna, 2009, Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation, Am J Transplant, 9, 1158, 10.1111/j.1600-6143.2009.02576.x Murali, 2016, Predictors of successful downstaging of hepatocellular carcinoma outside milan criteria, Transplantation, 100, 2391, 10.1097/TP.0000000000001402 Ravaioli, 2008, Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria, Am J Transplant, 8, 2547, 10.1111/j.1600-6143.2008.02409.x Massarollo, 2016, Favorable long-term outcome in patients submitted to liver transplantation after downstaging of hepatocellular carcinoma according to a brazilian selection protocol, Transplant Proceed, 48, 2338, 10.1016/j.transproceed.2016.06.029 Galle, 2017, The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy, J Hepatol, 67, 173, 10.1016/j.jhep.2017.03.007 2020 van Meer, 2015, Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands, J Hepatol, 63, 1156, 10.1016/j.jhep.2015.06.012 van Meer, 2016, Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands, Eur J Gastroenterol Hepatol, 28, 352, 10.1097/MEG.0000000000000527 Lencioni, 2010, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Semin Liver Dis, 30, 52, 10.1055/s-0030-1247132 Bova, 2013, Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies, Cardiovasc Intervent Radiol, 36, 433, 10.1007/s00270-012-0458-1 Duvoux, 2012, Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria, Gastroenterology, 143, 986-94 e3, 10.1053/j.gastro.2012.05.052 Putter, 2007, Tutorial in biostatistics: competing risks and multi-state models, Stat Med, 26, 2389, 10.1002/sim.2712 Core Team, 2013 de Wreede, 2010, The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models, Comput Methods Progr Biomed, 99, 261, 10.1016/j.cmpb.2010.01.001 Park, 2015, Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study, Liver Int, 35, 2155, 10.1111/liv.12818